Dr. Reddy’s receives EIR for FTO-3 Bachupally plant
During the inspection, the facility received 10 observations
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
USFDA
Aparna Group forays into pharma gets USFDA clearance for pharma manufacturing unit
Aparna Pharmaceuticals announced that its manufacturing facility, Aparna Organics, located in Pydibhimavaram, Srikakulalam, Andhra…
Zydus gets tentative USFDA approval for Dexamethasone Tablets USP, 1 mg
Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye…
Zydus gets USFDA nod for Dexamethasone Tablets USP, 0.5 mg, 0.75 mg, 1.5 mg, 4 mg and 6 mg and…
Dexamethasone is used to treat a number of different conditions, such as inflammation (swelling), severe allergies, adrenal…
Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg
Gabapentin is indicated for the management of Postherpetic Neuraligia (PHN)
Unichem gets USFDA nod for Doxazosin Tablets USP, 1 mg, 2 mg, 4 mg and 8 mg
Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure
Caplin Steriles gets USFDA approval for Ofloxacin Otic Solution
Ofloxacin Otic Solution 0.3% is used as anti-infective (antibacterial) for otic (ear) use
Akums launches Lasmiditan Tablet for migraine management
The medication is formulated to interrupt pain signals to the brain and address nerve inflammation contributing to migraine…
Strong performance in US market to support Indian pharma’s growth in FY2024: ICRA
Revenues of ICRA’s sample set of companies to expand by 9-11 per cent in FY2024, OPM to improve by 150-200 bps to 22-23 per cent…
Akums launches Doxylamine + Pyridoxine ER tablets
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy